Rezvilutamide (Rez) versus bicalutamide (Bic) plus androgen-deprivation therapy (ADT) in high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC): 5-year outcomes of the phase 3 CHART trial.

A group of women who lined up to use a men’s restroom at a highway rest area after the women’s facilities became overcrowded has sparked debate online, with some criticizing the move as an invasion of ...

Ferry passengers have been warned they could face long queues and delays travelling through the Port of Dover over the Bank Holiday due to EU border checks. The port is preparing for 18,000 travellers ...

Comeback from long-course ADT with relugolix (rel) and darolutamide (daro) in hormone-sensitive prostate cancer (PC) (CLEARED). This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I.

Each day we make choices in our lives that affect the environment, the climate, and other species. From what we eat to how many children we decide to have, there’s a lot we can do to “choose wild” and ...